Cross TA Teams Head, Global Epidemiology
Janssen, Switzerland
Daniel Rosenberg, PhD MPH, Cross Therapy Area Teams Head, Global Epidemiology, Janssen Pharmaceuticals, Johnson & Johnson.
- Long experience developing, implementing, and leading real-world evidence (RWE) research and public/patient health focused Teams and Programs in the pharmaceutical , hospital-based and community-level settings. Special focus on rare diseases and interest in public-private partnership to generate high quality real-world data.
